stockrow
Tuesday 3 November 2026
Export CI’s income statement to Excel — free account
Cigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
- Revenue
- +6.68%
- EPS
- +10.2%
- Free cash flow
- +66.9%
- Total debt
- +3.61%
Quarter to June 2026, against a year earlier
294.97
0.22
−0.07%
Follow CI
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
12.72 | 12.41 | 11.31 | 11.41 |
P/S ratio |
0.29 | 0.27 | 0.25 | 0.26 | |
P/FCF ratio |
10.31 | 8.75 | 9.15 | 7.96 | |
P/Operating CF |
22.43 | 11.94 | 61.97 | (172.21) | |
P/B ratio |
1.82 | 1.75 | 1.65 | 1.69 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.39 | 0.35 | 0.34 | 0.35 | |
EV/EBITDA |
8.93 | 8.12 | 7.61 | 7.73 | |
EV/Operating CF |
12.08 | 10.12 | 10.66 | 9.54 | |
EV/FCF |
14.07 | 11.59 | 12.26 | 10.76 | |
Quick Ratio |
0.74 | 0.72 | 0.72 | 0.74 | |
Current Ratio |
0.74 | 0.72 | 0.72 | 0.74 | |
Net Debt/EBITDA |
8.55 | 7.76 | 7.93 | 7.68 | |
Debt/Assets |
21.56% | 19.92% | 20.16% | 20.29% | |
Debt/Equity |
0.81 | 0.75 | 0.73 | 0.74 | |
Asset Turnover |
1.70 | 1.75 | 1.83 | 1.83 | |
Operating CF/Net income |
1.83 | 4.98 | 0.68 | (0.25) | |
Capex/Depreciation |
(0.40) | (0.45) | (0.41) | (0.45) | |
Interest Coverage |
7.43 | 6.48 | 6.61 | 7.52 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.82% | 4.98% | 5.43% | 4.84% | |
Intangible Assets out of Total Assets |
0.47 | 0.47 | 0.48 | 0.46 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.96) | (1.03) | (1.04) | (1.01) | |
Graham Number |
283.89 | 279.90 | 292.81 | 297.88 | |
Earnings Yield |
7.86% | 8.06% | 8.84% | 8.77% | |
Free Cash Flow Yield |
9.70% | 11.43% | 10.93% | 12.57% | |
Revenue per Share |
262.30 | 271.69 | 260.69 | 272.52 | |
Operating CF per Share |
12.85 | 23.05 | 4.30 | (1.60) | |
Capex per Share |
(1.05) | (1.21) | (1.02) | (1.13) | |
Free Cash Flow per Share |
11.81 | 21.84 | 3.29 | (2.73) | |
Cash per Share |
22.66 | 28.78 | 26.79 | 23.95 | |
Shareholders Equity per Share |
158.00 | 156.98 | 161.53 | 163.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
158.00 | 156.98 | 161.53 | 163.16 | |
Free Cash Flow |
3,140.00 | 5,827.00 | 864.00 | (718.00) | |
Working Capital |
(14,512.00) | (15,795.00) | (14,886.00) | (14,482.00) | |
Capital Expenditures |
(278.00) | (322.00) | (267.00) | (297.00) | |
Net Current Asset Value |
(73,964.00) | (75,498.00) | (73,104.00) | (73,092.00) | |
EV/EBIT |
11.59 | 10.57 | 9.80 | 9.85 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
8.49 | 7.98 | 7.31 | 7.28 | |
| Other line items | |||||
Average Receivables |
34,159.50 | 30,738.00 | 30,992.00 | 35,113.50 | |
Average Payables |
38,481.50 | 39,375.50 | 36,689.00 | 38,016.00 | |
Average Assets |
157,779.00 | 156,900.00 | 151,962.00 | 154,366.50 | |
Average Common Equity |
42,156.00 | 41,558.50 | 41,428.00 | 41,670.00 |
Columns are period end dates